Accelerated partnerships critical to ensuring malaria elimination goals

Published on January 19, 2013 at 6:35 AM · No Comments

Writing in the Huffington Post's "Impact" blog in advance of the Monitoring & Evaluation Reference Group (MERG) meeting convened by the Roll Back Malaria Partnership and taking place in Namibia this week, Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, interviews Roly Gosling, an international expert on malaria and current head of the Malaria Elimination Initiative at the University of California, San Francisco, "regarding malaria elimination, its importance, and why the Global Fund is critical to achieving that goal worldwide."

According to the interview transcript and accompanying video, Gosling discusses the "difference between malaria control, elimination and eradication"; talks about the relevance of the MERG meeting "to those who want to fight malaria"; and examines the role the Global Fund to Fight AIDS, Tuberculosis and Malaria has played in malaria control and elimination, among other topics. "It is clear that accelerated partnerships are critical to ensuring elimination goals, thanks to Dr. Roly Gosling and the Global Health Group at UCSF for this timely insight," Chesire concludes (1/17).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Posted in: Disease/Infection News | Healthcare News

Tags: , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Common anti-malaria medicine could have significant impact on colorectal cancer